Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry.
Emelia StuartSudeep BanerjeeJorge de la TorreYu WangNorman ScherzerAdam M BurgoyneLisa ParryPaul T FantaSonia RamamoorthyJason K SicklickPublished in: Journal of surgical oncology (2019)
We find that disease recurrence remains prevalent in one-third of patients treated during the imatinib-era.